V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002849 | 240007370 | null | 61.5 | Curative (C) | 2017-03-18 | 2017-04-12 | Alemtuz+Fludara+Melphalan RIC MUD | 01 | N | CHLORAMBUCIL + RITUXIMAB | 101758104 |
| 240000288 | 240007374 | 1.62 | 84.75 | Curative (C) | 2019-11-18 | 2019-11-30 | CHOP - 21 days | 02 | N | RUXOLITINIB | 100026639 |
| 240000359 | 240007376 | 0 | 77 | null | 2020-02-03 | 2020-02-04 | AML Interim Guidelines FLAG-Ida | 02 | null | ANAGRELIDE | 100257248 |
| 240000443 | 240007379 | 1.52 | 55.7 | null | 2016-11-14 | 2019-04-04 | null | 01 | N | CYCLOPHOSPHAMIDE HIGH DOSE | 100116826 |
| 240000506 | 240007380 | 1.62 | 123 | Curative (C) | null | 2019-05-07 | Cyclophosphamide High Dose | null | null | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 100084458 |
| 240000533 | 240007382 | 1.61 | 72 | null | 2019-12-10 | 2019-12-17 | R CODOX M | 02 | null | VENETOCLAX | 100823555 |
| 240000600 | 240007383 | 1.81 | 61.1 | Curative (C) | null | 2018-09-18 | DA-EPOCH-R | null | null | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 101379375 |
| 240000612 | 240007384 | 1.72 | 93.6 | null | 2018-07-24 | 2018-07-26 | INTERFERON | N | null | TRANSPLANT CAR-T CELLS - AXICABTAGENE CILOLEUCEL | 101716921 |
| 240000708 | 240007387 | 1.66 | 76.8 | null | 2021-10-02 | 2021-10-03 | AML Interim Guidelines FLAG-Ida | N | null | FLAIR TRIAL | 101863435 |
| 240000821 | 240007390 | 1.72 | null | null | 2017-03-20 | 2017-05-20 | null | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100969049 |
| 240000877 | 240007391 | 1.63 | 66.7 | 03 | 2018-05-16 | 2018-06-09 | CHLORAMBUCIL + OBINUTUZUMAB | 01 | null | VENETOCLAX | 100225439 |
| 240000970 | 240007393 | 1.6 | 81.6 | null | 2022-04-16 | 2022-04-16 | Obinutuzumab + Venetoclax | 02 | Y | CLADRIBINE + CYTARABINE + MITOXANTRONE | 100916897 |
| 240001287 | 240007397 | 1.91 | 39 | null | 2017-06-21 | 2017-06-21 | DA 3 + 10 | null | N | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 100843054 |
| 240001584 | 240007399 | 1.6 | 60 | null | 2021-01-23 | 2021-01-27 | Rituximab + Venetoclax | 02 | null | TRIAL | 100066401 |
| 240001659 | 240007401 | 1.75 | 99.6 | Curative (C) | 2018-02-26 | 2018-03-31 | null | 01 | null | GEMTUZUMAB OZOGAMICIN | 100079215 |
| 240001691 | 240007402 | 1.57 | 117 | Curative (C) | 2019-02-26 | 2019-03-06 | null | 02 | N | CYTARABINE HIGH DOSE | 100594207 |
| 240001694 | 240007403 | 1.75 | 57.7 | Adjuvant (A) | 2016-04-23 | 2016-10-08 | null | Y | N | NOT MATCHED | 100997278 |
| 240001701 | 240007404 | 1.72 | 97 | Curative (C) | 2018-08-06 | 2018-08-09 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | null | LIPOSOMAL DAUNORUBICIN + LIPOSOMAL CYTARABINE (VYXEOS) | 100051453 |
| 240001816 | 240007406 | 1.76 | 69 | Curative (C) | 2018-06-12 | 2018-08-19 | Dasatinib | 02 | N | BUSULFAN | 101132644 |
| 240001819 | 240007407 | 1.65 | 72.5 | Curative (C) | 2020-10-22 | 2020-10-24 | Ibrutinib + Rituximab | 02 | N | RUXOLITINIB | 101391358 |
| 240001828 | 240007408 | 1.6 | 99 | 03 | 2017-12-05 | 2017-12-06 | Methotrexate intrathecal | 02 | N | IDARUBICIN | 100548346 |
| 240001877 | 240007409 | 1.63 | 60 | null | 2017-04-30 | 2017-04-30 | DA | 02 | null | QUIZARTINIB | 100172582 |
| 240001955 | 240007411 | 1.77 | 88.3 | Curative (C) | null | 2021-11-18 | NIVOLUMAB | null | N | IMATINIB | 101150207 |
| 240002149 | 240007415 | 0 | 17.7 | Palliative (P) | 2019-02-26 | 2019-02-26 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | N | DACARBAZINE + DOXORUBICIN | 100262396 |
| 240002287 | 240007418 | 1.6 | 91 | null | 2019-06-02 | 2020-05-20 | AML MyeChild 01 FLA-Idarubicin | N | null | AML DOWNS HA | 101567333 |
| 240002338 | 240007419 | 1.7 | 91.7 | null | 2018-03-31 | 2018-03-31 | Quizartinib | 02 | null | AML16 TRIAL | 101804494 |
| 240002419 | 240007420 | 1.69 | 0 | Curative (C) | 2019-02-06 | 2019-02-06 | DA 3+8 | 02 | null | ANAGRELIDE | 101242152 |
| 240002433 | 240007421 | 1.5 | 156.4 | Curative (C) | 2016-11-17 | 2016-12-15 | CVP R | null | null | RUXOLITINIB | 101072073 |
| 240002468 | 240007422 | 1.67 | 82.1 | null | 2018-04-28 | 2018-07-23 | ALL UKALL2011 Maintenance C1 | 01 | null | TRANSPLANT AMSACRINE + ANTI-THYMOCYTE GLOBULIN + BUSULFAN + CYCLOPHOSPHAMIDE + CYTARABINE + FLUDARABINE | 101132559 |
| 240002831 | 240007426 | 1.73 | 46.5 | Adjuvant (A) | 2017-01-16 | 2017-01-16 | AML MyeChild 01 IT Cyt | 02 | N | TRIPLE INTRATHECAL | 100005624 |
| 240000178 | 240007427 | 0 | 82 | null | 2018-11-27 | 2018-11-27 | CYCLOPHOSPHAMIDE + FLUDARABINE | Y | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 101441540 |
| 240000200 | 240007428 | 0 | 80 | 03 | 2016-12-30 | 2016-12-30 | AML MyeChild 01 FLA | 02 | N | DABRAFENIB + TRAMETINIB | 100986903 |
| 240000359 | 240007429 | 1.79 | 97.5 | Curative (C) | 2019-09-15 | 2019-09-15 | CYCLO + RITUXIMAB + VINCRISTINE | 02 | N | RUXOLITINIB | 100257248 |
| 240001287 | 240007433 | 1.64 | 9.5 | null | 2019-12-16 | 2019-12-23 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100843054 |
| 240002149 | 240007434 | 1.85 | 108 | Curative (C) | 2021-01-09 | 2021-06-09 | Cytarabine High Dose | 02 | N | CVP R | 100262396 |
| 240002468 | 240007435 | 1.88 | 73.9 | Curative (C) | 2019-12-23 | 2019-12-23 | CVP R | null | N | CYCLOPHOSPHAMIDE + FLUDARABINE | 101132559 |
| 240000696 | 240007645 | null | null | null | null | 2017-10-05 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101592742 |
| 240000800 | 240007688 | 1.89 | 74 | null | null | 2018-09-03 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101478560 |
| 240000872 | 240007711 | null | null | null | null | 2016-11-30 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101466427 |
| 240000901 | 240007722 | null | null | null | null | 2018-05-08 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100857006 |
| 240000908 | 240007726 | null | null | null | null | 2018-06-28 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101326969 |
| 240000918 | 240007733 | null | null | null | null | 2017-05-27 | null | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100007232 |
| 240000949 | 240007751 | null | null | null | null | 2017-03-29 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100796352 |
| 240000975 | 240007767 | null | null | null | null | 2018-11-30 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100011226 |
| 240000996 | 240007776 | null | null | null | null | 2019-01-30 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101352952 |
| 240001023 | 240007789 | null | null | null | null | 2016-12-16 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101187865 |
| 240001047 | 240007804 | null | null | null | 2017-11-17 | 2017-11-21 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101566637 |
| 240001083 | 240007822 | null | null | null | null | 2017-05-26 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100277792 |
| 240001106 | 240007833 | null | null | null | null | 2018-01-30 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101178428 |
| 240001175 | 240007859 | null | null | null | null | 2017-07-27 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100641333 |